Skip to content

Latest Perspectives
Diagnostic Biomarker
Education CME
Our Community

English
日本語
한국어
Tiếng Việt

Search

Home/Latest Perspectives/World Heart Day/Thank you for signing up!

Thank you for signing up!

World Heart Day

Thank you for signing up!

21 August 2024

Gap report infographic cover page

Download the clinician HF gap report infographic here

Related Articles

Related Links

ACC 2025 Spotlight: DROP-Asian ACS Interim Analysis Highlights Regional Gains in NSTEMI Care
Empowering the Everyday: AI-enabled CGM Is the Next Leap in Diabetes Care
Lipoprotein(a) in clinical practice
STRONG-HF Japan Study
Innovative Strategies to Optimise Heart Failure GDMT at Prince Wales Hospital’s Heart Failure Clinic
STRONG-HF Recommended in Updated China National Heart Failure Guideline 2023
Rapid Titration (RaT) Pathway For Optimising Heart Failure GDMT with comprising several hospitals in Northland
Reducing Mortality and Readmission with HF Multidisciplinary Model of Care
Culturally Sensitive Diabetes Care
What Causes Falsely High & Low HbA1c Reading?
Menopause and Diabetes
Screening for Occult Heart Failure (HF) in Type 2 Diabetes Mellitus (T2DM) using NT-proBNP
Value of biomarker in HFpEF Diagnosis
Sex-specific Differences in Heart Failure
Management of CVD in Patients with Diabetes
Heart Failure Care Beyond City Limits: Insights from a Cardiologist
Implementation of STRONG-HF protocol in heart failure management: an Australian perspective
When every minute counts: A deep dive into IJN Malaysia’s quest for rapid triage for chest pain patients in the ED
Quantum leap in reducing rehospitalization in HF by 70-80% – How and where?
Heart failure management in Australia and the role of NT-proBNP in monitoring and treatment
Perioperative myocardial injury (PMI) management: Challenges and feasibility of active screening in non-cardiac surgeries
Heart Failure Management in India – Overcoming Present Challenges
Rational use of troponin and optimal management of cardiovascular diseases</strong>
The evidence for 0/1-hour algorithm for Asia? DROP-Asian ACS Study
Process Optimization for Emergency hs-TnT Detection
Clinical Application NT-proBNP in CKD (Chronic Kidney Diseases) Patients with Cardiovascular Diseases
High Sensitivity Troponin vs Conventional Troponin: An Expert View
The rationale for the use of hs-cTn in the optimal management of ACS
STROKESTOP II Study: Precision risk screening for atrial fibrillation in elderly
Atrial Fibrillation in Elderly: Screening tools and role of NT-proBNP
Advantages of early NT-proBNP testing in patients suspected with heart failure
NT-proBNP: Increasing Clinical Confidence in Heart Failure Management
What is the Peptide for Life initiative?
Heart Failure in Asia – Present Challenges and Future Strategies
Perioperative Myocardial Infarction in Non-Cardiac Surgery – Why Measuring Troponin is Important?
Heart Failure Prevention in T2DM – Essence of JCS/JDS joint consensus
CANVAS (CANagliflozin cardioVascular Assessment Study): NT-proBNP and CVD risk reduction
What should we take note of when using hs-TnT for CKD patient?
Clinical Relevance – High-Sensitivity Troponin Results Influenced by Age
Clinical Relevance of hs-TnT gender specific cut-offs
Recommended Steps to Implement 0h/1h Algorithm in Asia
Benefits of 0h/1h Algorithm in a Thai Institution
Benefits of 0h/1h Algorithm to Patients in Asia
How will NT-proBNP testing evolve in the future?
Is NT-proBNP validated for different population groups?
Reference ranges for NT-proBNP & hs-TnT in Asian populations
Benefits of the 0h/1h algorithm in a Japanese institution
Patient Case Studies Using 0h/1h Algorithm
BNP vs NT-proBNP: An Expert View
Impact of ARNi Therapy on Natriuretic Peptide Use
How to Use NT-proBNP for Prognosis and Monitoring?
What Should Hospitals Consider when Implementing Rapid Algorithm?
TRAPID-AMI sub-study: Use of very low concentration of hs-TnT to rule out AMI using a single blood test
Benefits of hs-Tn 0h/1h Algorithm in ED & Hospital
TRAPID-AMI Study: hs-TnT for Rapid Rule In/ Out of AMI
Benefits of hs-Tn 0h/1h Algorithm to Chest Pain Patients
How NT-proBNP Made a Difference: Dr Januzzi’s Patient Story
Impact of High-Sensitivity Cardiac Troponin (hs-Tn) on Further Cardiac Testing in Suspected AMI Patients
Advantages of Switching from Conventional to High-Sensitivity Troponin
How hs-TnT Made a Difference – Dr Twerenbold’s Story
How NT-proBNP Made a Difference: Dr Richards’ Patient Story
Natriuretic Peptides in the Latest ESC & AHA HF Guidelines
Role of Natriuretic Peptides in Patients with Dypsnea

Cardio ThinkLab is a scientific educational portal for healthcare professionals passionate about cardiovascular, renal, and metabolic disease management. By keeping a finger on the pulse, we offer the latest scientific perspectives and diagnostics insights garnered from leading experts to support the continuum of your patient care.

About Us
Legal Statement
Privacy Policy
Cookie Policy
Cookie Preference

English
日本語
한국어
Tiếng Việt

© 2026. Roche Diagnostics Asia Pacific Pte Ltd.

Disclaimer

This website contains information targeted at healthcare professionals and could contain information otherwise not accessible, approved or valid in your country. Please be aware that we do not take any responsibility for you accessing information which may not comply with any legal process, regulation, registration or usage in the country of your origin. Please also be aware that the information in this website should not be used to diagnose, treat, cure or prevent any disease without the advice of a qualified medical professional, and does not replace medical advice or a medical examination.

This website is restricted for healthcare professionals only.

The information contained in Cardio ThinkLab is intended for healthcare professionals only.
Click "OK" if you are a healthcare professional.

OK

Want to receive the latest updates?

Sign up now